Proinflammatory and Anti-inflammatory Cytokines as Mediators in the Pathogenesis of Septic Shock

This publication has 72 references indexed in Scilit:

• Glycosylated recombinant human tumor necrosis factor binding protein-1 reduces mortality, shock, and production of tumor necrosis factor in rabbit Escherichia coli sepsis
  Critical Care Medicine, 1995
• A MAP Kinase Targeted by Endotoxin and Hyperosmolarity in Mammalian Cells
  Science, 1994
• THE EFFECTS OF HUMAN RECOMBINANT INTERLEUKIN-1 RECEPTOR ANTAGONIST (IL-1ra) ON PLASMA LEVELS OF PROSTAGLANDINS AND LEUKOTRIENES IN SEPTIC PATIENTS
  Critical Care Medicine, 1994
• Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: A randomized, open-label, placebocontrolled multicenter trial
  Critical Care Medicine, 1994
• Tumour necrosis factor soluble receptors behave as acute phase reactants following surgery in patients with rheumatoid arthritis, chronic osteomyelitis and osteoarthritis
  Clinical and Experimental Immunology, 1993
• Activation of the Sphingomyelin Signaling Pathway in Intact EL4 Cells and in a Cell-Free System By IL-1β
  Science, 1993
• Myristyl acylation of the tumor necrosis factor alpha precursor on specific lysine residues.
  The Journal of Experimental Medicine, 1992
• Activation of Coagulation after Administration of Tumor Necrosis Factor to Normal Subjects
  New England Journal of Medicine, 1990
• Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits.
  Journal of Clinical Investigation, 1988
• Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition.
  Journal of Clinical Investigation, 1988